UROVIST CYSTO Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Urovist Cysto, and what generic alternatives are available?
Urovist Cysto is a drug marketed by Bayer Hlthcare and is included in two NDAs.
The generic ingredient in UROVIST CYSTO is diatrizoate meglumine. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the diatrizoate meglumine profile page.
Summary for UROVIST CYSTO
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 32 |
Patent Applications: | 890 |
Formulation / Manufacturing: | see details |
DailyMed Link: | UROVIST CYSTO at DailyMed |
US Patents and Regulatory Information for UROVIST CYSTO
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Hlthcare | UROVIST CYSTO | diatrizoate meglumine | SOLUTION;URETERAL | 087729-001 | Sep 23, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bayer Hlthcare | UROVIST CYSTO PEDIATRIC | diatrizoate meglumine | SOLUTION;URETERAL | 087731-001 | Sep 23, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |